Quality Evaluation of Anticoagulant Therapy in Patients Who Taking Warfarin in Our Hospital
10.6039/j.issn.1001-0408.2016.15.05
- VernacularTitle:我院服用华法林患者抗凝治疗质量评价
- Author:
Lingling LI
;
Ying LI
;
Liping DU
;
Wen LI
;
Dan MEI
- Publication Type:Journal Article
- Keywords:
Warfarin;
Anticoagulant therapy;
Time in therapeutic range;
International normalized ratio;
Quality evaluation
- From:
China Pharmacy
2016;27(15):2032-2034
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data sup-porting for strengthening the management of these patients. METHODS:A retrospective analysis of related clinical data of 214 pa-tients who meet the inclusion criteria was performed. RESULTS:The average time for patients took warfarin was (321.64 ± 189.50)d,average times for tested INR was(12.01±7.03)times in clinic;when anticoagulant therapy,INR<2.0 accounted for 51.96%,2.0≤INR≤3.0 accounted for 39.13%,and INR>3.0 accounted for 8.91%;patients with target INR≤2.0 accounted for 45.33%,target INR=2.5 accounted for 38.32%,and target INR≥3.0 accounted for 0.93%;the average TTR was (50.80 ± 22.32)%;and there was no statistical significance in the TTR of different ages and diseases(P>0.05). CONCLUSIONS:The anti-coagulant therapy in some patients who took warfarin shows poor quality,it needs strengthening the quality management to make it safe and effective.
